Your browser doesn't support javascript.
loading
Combination therapy of disseminated Fusarium oxysporum infection with terbinafine and amphotericin B.
Rothe, A; Seibold, M; Hoppe, Th; Seifert, H; Engert, A; Caspar, C; Karthaus, M; Fätkenheuer, G; Bethe, U; Tintelnot, K; Cornely, O A.
Affiliation
  • Rothe A; Klinik I für Innere Medizin, Universität zu Köln, Joseph-Stelzmann-Str. 9, 50931 Cologne, Germany.
Ann Hematol ; 83(6): 394-7, 2004 Jun.
Article in En | MEDLINE | ID: mdl-14648020
ABSTRACT
A case of disseminated infection with Fusarium oxysporum following chemotherapy of acute myelogenous leukemia is reported. Antifungal treatment was successful with a 13-day course of oral terbinafine 250 mg t.i.d. in combination with amphotericin B deoxycholate 1.0-1.5 mg/kg qd and subsequently intravenous liposomal amphotericin B 5 mg/kg qd. Preceding monotherapy with amphotericin B deoxycholate 1.0-1.5 mg/kg qd had not stopped the progression of infection. The combination therapy described here represents a novel approach to the treatment of Fusarium spp. in the immunocompromised host in whom Fusarium spp. are known to cause disseminated infection with high mortality.
Subject(s)
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Amphotericin B / Dermatomycoses / Fusarium / Antifungal Agents / Naphthalenes Limits: Humans / Male / Middle aged Language: En Journal: Ann Hematol Year: 2004 Document type: Article
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Amphotericin B / Dermatomycoses / Fusarium / Antifungal Agents / Naphthalenes Limits: Humans / Male / Middle aged Language: En Journal: Ann Hematol Year: 2004 Document type: Article